Misplaced Pages

Estramustine

Clinical data
Trade names	Emcyt, Estracyt
Other names	EM; EaM; Leo 275; Ro 21-8837; Estradiol 3-(bis(2-chloroethyl)carbamate) ester; Estra-1,3,5(10)-triene-3,17β-diol 3-(bis(2-chloroethyl)carbamate) ester
Drug class	Chemotherapeutic agent; Estrogen; Estrogen ester
ATC code	L01XX11 (WHO)
Identifiers
IUPAC name phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate
CAS Number	2998-57-4
PubChem CID	259331
ChemSpider	227635
UNII	35LT29625A
KEGG	D04066
ChEBI	CHEBI:4868
ChEMBL	ChEMBL1575
CompTox Dashboard (EPA)	DTXSID8046458
ECHA InfoCard	100.019.161
Chemical and physical data
Formula	C23H31Cl2NO3
Molar mass	440.41 g·mol
3D model (JSmol)	Interactive image
SMILES C12CC3(1CC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
InChI InChI=1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1 Key:FRPJXPJMRWBBIH-RBRWEJTLSA-N

Estramustine (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, BANTooltip British Approved Name) is an estrogen and cytostatic antineoplastic agent which was never marketed. It is a carbamate derivative of estradiol and acts in part as a prodrug of estradiol in the body. Estramustine phosphate, the C17β phosphate ester of estramustine and a prodrug of estramustine, estromustine, estradiol, and estrone, is marketed and used in the treatment of prostate cancer.

Synthesis

Estramustine is a carbamate derivative of the natural hormone, estradiol. The amine (ClCH₂CH₂)₂NH is treated with phosgene to give the acid chloride of normustine. This reacts with the phenolic hydroxyl group of estradiol in the presence of a base to give estramustine.

See also

• Estradiol mustard
• List of hormonal cytostatic antineoplastic agents
• List of estrogen esters § Estradiol esters

References

1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 502–. ISBN 978-1-4757-2085-3.
2. ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 406–. ISBN 978-3-88763-075-1.
3. Niculescu-Duvăz I, Cambanis A, Tărnăuceanu E (March 1967). "Potential anticancer agents. II. Urethan-type nitrogen mustards of some natural sex hormones". Journal of Medicinal Chemistry. 10 (2): 172–174. doi:10.1021/jm00314a009. PMID 6034059.
4. Sk UH, Dixit D, Sen E (October 2013). "Comparative study of microtubule inhibitors--estramustine and natural podophyllotoxin conjugated PAMAM dendrimer on glioma cell proliferation". European Journal of Medicinal Chemistry. 68: 47–57. doi:10.1016/j.ejmech.2013.07.007. PMID 23954240.

This article about a steroid is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Abandoned drugs
• Antiandrogens
• Antigonadotropins
• Antineoplastic drugs
• Carbamates
• Chloroethyl compounds
• Secondary alcohols
• Estradiol esters
• Estranes
• Estrogens
• Hormonal antineoplastic drugs
• Human drug metabolites
• Mitotic inhibitors
• Nitrogen mustards
• Organochlorides
• Drugs developed by Pfizer
• Steroid stubs
• Antineoplastic and immunomodulating drug stubs